Therefore, this prospective single arm open label study recruited women being treated with either adjuvant or neo-adjuvant chemotherapy for stage II or III BC, with the aim to determine whether the use of the Inje cocktail to measure changes in CYP activity over time is feasible and safe. Here, PPIG is linked to breast cancer.